HRS Bibliography

Bibliography Search
Export 23 results:
Filters: Author is Dana P Goldman  [Clear All Filters]

B

Goldman DP, Zheng Y, Girosi F, et al. The benefits of risk factor prevention in Americans aged 51 years and older. Am J Public Health. 2009;99(11):2096-101. doi:10.2105/AJPH.2009.172627.
http://www.ncbi.nlm.nih.gov/pubmed/19762651?dopt=Abstract

C

Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient?. Proc Natl Acad Sci U S A. 2002;99(16):10929-34. doi:10.1073/pnas.162086599.
http://www.ncbi.nlm.nih.gov/pubmed/12140364?dopt=Abstract

D

Michaud P-C, Goldman DP, Lakdawalla D, Gailey A, Zheng Y. Differences in health between Americans and Western Europeans: Effects on longevity and public finance. Soc Sci Med. 2011;73(2):254-63. doi:10.1016/j.socscimed.2011.05.027.
http://www.ncbi.nlm.nih.gov/pubmed/21719178?dopt=Abstract
Snider JThornton, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The Disability burden of COPD. COPD. 2012;9(5):513-21. doi:10.3109/15412555.2012.696159.
http://www.ncbi.nlm.nih.gov/pubmed/22721264?dopt=Abstract
Gaudette É, Goldman DP, Messali A, Sood N. Do Statins Reduce the Health and Health Care Costs of Obesity?. Pharmacoeconomics. 2015;33(7):723-34. doi:10.1007/s40273-014-0234-y.
http://www.ncbi.nlm.nih.gov/pubmed/25576147?dopt=Abstract

H

Michaud P-C, Lakdawalla D, Goldman DP, Sood N, Cong Z. Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data.; 2010.
Lowsky DJ, S Olshansky J, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69(6):640-9. doi:10.1093/gerona/glt162.
http://www.ncbi.nlm.nih.gov/pubmed/24249734?dopt=Abstract
Goldman DP, Zissimopoulos JM. High out-of-pocket health care spending by the elderly. Health Aff (Millwood). 2003;22(3):194-202. doi:10.1377/hlthaff.22.3.194.
http://www.ncbi.nlm.nih.gov/pubmed/12757285?dopt=Abstract
Auerbach A, Charles KK, Coile C, et al. How the growing gap in life expectancy may affect retirement benefits and reforms. The Geneva Papers on Risk and Insurance - Issues and Practice. 2017;42(3):475-499. doi:10.1057/s41288-017-0057-0.

L

Agus DB, Gaudette É, Goldman DP, Messali A. The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older. Song Q, ed. PLoS One. 2016;11(11):e0166103. doi:10.1371/journal.pone.0166103.
http://www.ncbi.nlm.nih.gov/pubmed/27902693?dopt=Abstract

M

MacEwan JP, Gill TM, Johnson K, et al. Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions. The journal of nutrition, health & aging. 2018. doi:10.1007/s12603-018-1104-7.
Goldman DP, Zissimopoulos JM, Yang L. Medical Expenditure Measures in the Health and Retirement Study. Forum Health Econ Policy. 2011;14(3):4. doi:10.2202/1558-9544.1267.
http://www.ncbi.nlm.nih.gov/pubmed/24049512?dopt=Abstract
Goldman DP, Maestas N. Medical Expenditure Risk and Household Portfolio Choice. Santa Monica, CA: RAND Labor and Population Program; 2007. doi:https://doi.org/10.7249/WR325-1.

S

Joyce GF, Goldman DP, Leibowitz AA, Alpert A, Bao Y. A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved. 2005;16(1):19-28. doi:10.1353/hpu.2005.0013.
http://www.ncbi.nlm.nih.gov/pubmed/15741706?dopt=Abstract

U

Goldman DP, Lakdawalla D, Michaud P-C, Zheng Y, Gailey A. Understanding the Economic Consequences of Shifting Trends in Population Health. Cambridge, MA: National Bureau of Economic Research; 2009. doi:10.3386/w15231.
Lakdawalla D, Goldman DP, Michaud P-C, et al. U.S. Pharmaceutical Policy In A Global Marketplace. Health Affairs. 2009;28(1):w138-w150. doi:10.1377/hlthaff.28.1.w138.
St Clair PA, Gaudette É, Zhao H, Tysinger B, Seyedin R, Goldman DP. Using self-reports or claims to assess disease prevalence: It's complicated. Medical Care. 2017;55(8):782-788. doi:10.1097/MLR.0000000000000753.
http://www.ncbi.nlm.nih.gov/pubmed/28617703?dopt=Abstract